stockrowTakeda Pharmaceutical Co. (TAK) vs United Therapeutics Corporation (UTHR)
- Takeda Pharmaceutical Co. TAK 21.25 +0.90%
- United Therapeutics Corporation UTHR 564.88 −7.17%
Takeda Pharmaceutical Co. and United Therapeutics Corporation are both Drug Manufacturers Specialty & Generic companies. Takeda Pharmaceutical Co. is the larger, with a market value of $67.7B against $24.3B — 2.8× the size. United Therapeutics Corporation trades at the lower P/E: 19.7× against 32.0×. United Therapeutics Corporation grew revenue faster over the last twelve months: 1.89% against 0.66%. United Therapeutics Corporation has the higher net margin (38.6% vs 7.12%) and the higher return on invested capital (30.1% vs 0.00%). Across the 22 metrics below, United Therapeutics Corporation leads on 16 and Takeda Pharmaceutical Co. on 6.
Valuation
Profitability
| Metric | TAK | UTHR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.85% | 86.34% | 53.51% |
| Operating margin | 11.61% | 41.45% | 0.00% |
| Net margin | 7.12% | 38.61% | (2.45%) |
| Free cash flow margin | 0.00% | 27.21% | 0.00% |
| Return on equity | 0.00% | 19.13% | (0.80%) |
| Return on assets | 0.00% | 17.11% | (1.67%) |
| Return on invested capital | 0.00% | 30.13% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack